查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1998337

周邊血管醫療設備市場：2026-2032年全球市場預測（依產品類型、技術、材料、適應症、病患群體和最終用戶分類）

Peripheral Vascular Devices Market by Product, Technology Type, Material Type, Indication, Patient Types, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，周邊血管醫療設備市場價值將達到 155 億美元，到 2026 年將成長至 163.9 億美元，到 2032 年將達到 237.2 億美元，複合年成長率為 6.26%。

主要市場統計數據
基準年 2025 155億美元
預計年份：2026年 163.9億美元
預測年份 2032 237.2億美元
複合年成長率 (%) 6.26%

重點介紹臨床實務、醫療設備創新和醫療保健系統管理的機會和挑戰。

周邊血管醫療設備市場正處於三大因素的交會點：人口老化、疾病負擔的變化、治療方法的快速發展。臨床醫生越來越依賴各種醫療設備，從微創導管介入到開放性手術和血管移植。手術方式的多樣化推動了對整合式臨床路徑的需求日益成長，這些路徑旨在最佳化患者預後並控制成本。因此，醫院系統和門診手術中心正在重新審視藥品清單、醫療設備採用標準和庫存策略，以在常規血管介入治療中平衡療效和可重複性。

全面概述將改變周邊血管治療的臨床實踐、技術應用和競爭格局的變革性變化。

周邊血管醫療設備的臨床應用格局正經歷多重變革，重塑其應用模式與競爭格局。在導管設計、斑塊修復技術和支架材料不斷改進的推動下，微創技術正持續拓展至以往需要開放性手術治療的患者族群。這一趨勢得益於術中影像和導航技術的進步，這些技術提高了手術精度，並擴大了血管內治療的適應症。隨著臨床醫生和醫療系統越來越傾向於選擇能夠縮短恢復時間和住院時間的微創治療方法，製造商在設計下一代解決方案時，必須優先考慮易用性、與競爭對手產品的兼容性以及已證實的臨床療效。

分析檢視美國在 2025 年徵收的關稅如何影響醫療設備製造商的供應鏈結構、籌資策略和商業營運。

美國將於2025年實施的關稅調整迫使醫療設備製造商和經銷商重新評估其全球採購地點和契約製造夥伴關係。雖然關稅針對的是特定類別的原料和成品，但其更廣泛的影響正在加速企業對近岸外包機會、雙重採購法規以及關鍵零件生產垂直整合的考慮。製造商越來越重視估算包含關稅、運費波動和庫存持有成本在內的總到岸成本，並以此作為供應商選擇和資本投資決策的依據。因此，醫療設備開發商優先考慮與那些能夠提供地理分散、品質穩定且能夠根據需求波動柔軟性調整生產規模的供應商建立合作關係。

該方法整合了產品分類、程序技術、材料、臨床適應症、患者群體和最終用戶環境等方面的詳細細分見解，以幫助制定有針對性的商業化策略。

產品層面的多樣性決定了臨床和採購相關人員如何評估周邊血管產品線。市場涵蓋球囊擴張裝置、各種導管、移植物、導管導引線、下腔靜脈濾器、導引器、斑塊修飾裝置、支架和血管閉塞系統。在導管方面，長導管、中線導管和短導管之間的差異會影響手術方案的選擇、庫存管理以及臨床醫生培訓的重點。移植物的選擇取決於材料和生物學因素，生物移植物、可擴張聚四氟乙烯移植物和聚酯移植物各自具有獨特的操作特性和長期性能權衡。支架技術進一步分為球囊擴張型和自擴張式，臨床醫師根據病灶形態、血管大小和輸送需求進行選擇。

區域洞察揭示了全球主要區域的需求推動要素、法規環境、基礎設施能力和戰略重點，有助於制定市場進入和擴張計劃。

區域趨勢對周邊血管器械的採納、報銷和臨床應用有顯著影響。在美洲，成熟的醫療保健體系、完善的報銷機制和較高的手術量支持新型微創器械的快速普及；然而，不同的支付模式和醫院整合趨勢要求採用更為細緻的合約方式。相較之下，歐洲、中東和非洲則呈現出監管差異和基礎設施不平衡的複雜局面。歐洲市場傾向於優先考慮嚴謹的臨床證據和集中採購框架，而中東和非洲則可能優先考慮與當地臨床專長和供應鏈限制相契合的技術。這些差異要求企業制定適應性強的打入市場策略和有針對性的證據材料，以滿足特定區域的法規和臨床需求。

重點分析醫療設備製造商和服務供應商的競爭定位、創新重點領域、夥伴關係趨勢和策略挑戰等主要企業洞察。

周邊血管器械領域的主要企業正透過將器械的漸進式改善與平台層面的創新相結合，從而實現差異化競爭，提高手術效率並改善患者的長期預後。一些企業優先開發模組化系統，以增強與現有導管和影像平台的互通性；而另一些企業則專注於材料科學的突破，旨在最佳化輸送性能並降低再血管再阻塞。隨著越來越多的企業致力於提供能夠簡化臨床醫生工作流程並支持術中決策的整合式手術解決方案，醫療設備製造商與影像和數位醫療服務提供者之間的策略合作日益普遍。此外，與契約製造和區域生產基地的合作有助於確保供應鏈的柔軟性，並減輕貿易中斷的影響。

為幫助行業領導者確定投資優先順序、協調臨床證據策略以及最佳化供應鏈韌性以實現永續成長提供實用建議。

首先，優先進行能夠同時關注短期手術效果和長期患者終點的臨床證據項目。設計可操作的研究和註冊登記，使其能夠無縫融入常規臨床流程，從而加快臨床醫生接受度，並促進與保險公司的溝通。其次，在開發新型醫療設備時，應注重模組化和互通性，以減少臨床醫師訓練的阻力，並提高其與現有治療室的整合潛力。第三，提高供應鏈透明度，並實現採購管道多元化，以最大限度地減少關稅相關的成本波動和物流瓶頸的影響。將特定零件外包到近岸地區，並與替代供應商建立合作關係，可以在保持生產連續性的同時最佳化整體成本。

本報告概述了一種透明的調查方法，解釋了支撐本報告見解和建議的證據來源、分析框架和檢驗程序。

本調查方法結合了對臨床、監管和商業領域相關人員的訪談，以及對同行評審文獻、監管文件和公開臨床註冊資料的廣泛二次分析。一手研究包括與介入性心臟病專家、血管外科醫生、採購經理以及醫療設備製造商和契約製造(CMO) 的高階主管進行結構化對話，以了解營運限制和策略重點。二次研究整合了醫療設備附加檔、臨床試驗註冊資料、監管指導文件和已發表的療效研究，從而對性能特徵和手術趨勢進行多角度檢驗。

簡明扼要的結論，整合了對相關人員的影響，並提出了不斷發展的周邊血管器械生態系統中的策略重點。

周邊血管器械領域正經歷手術技術的快速發展、材料的創新以及經濟獎勵機制的轉變，所有這些因素都要求製造商和醫療系統採取靈活且基於循證醫學的策略。在許多適應症中，臨床路徑正朝著微創方向發展，凸顯了能夠在簡化的手術流程中提供穩定性能的器械的重要性。同時，監管機構和支付方的期望進一步加強了上市後監測和基於結果的證據，重申了長期數據收集和價值論證的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 周邊血管醫療設備市場：依產品分類

  • 氣球膨脹裝置
  • 導管
    • 長周邊靜脈導管
    • 中線導管
    • 短周邊靜脈導管
  • 接枝
    • 生物移植
    • ePTFE 接枝
    • 聚酯接枝
  • 導管導引線
  • 下腔靜脈濾器
  • 導引器
  • 斑塊修飾裝置
  • 支架
    • 球囊擴張型支架
    • 自動擴張型支架
  • 血管閉合裝置

第9章 周邊血管醫療設備市場：依技術類型分類

  • 微創手術
    • 血管成形術
    • 支架置入
  • 開放性手術
    • 心臟繞道手術
    • 切除術

第10章 周邊血管醫療設備市場：依材料類型分類

  • 金屬裝置
    • 鈷鉻合金
    • 鎳鈦諾
    • 不銹鋼
  • 非金屬裝置
    • 聚合物
    • 矽酮

第11章 周邊血管醫療設備市場：依適應症分類

  • 功能性周邊血管疾病
    • 慢性靜脈功能不全
    • 雷諾氏症
    • 靜脈曲張
  • 阻塞性周邊血管疾病
    • 動脈粥狀硬化
    • 血栓閉塞性脈管炎
    • 頸動脈疾病
    • 深層靜脈栓塞症
    • 淋巴水腫

第12章 依病患類型分類的周邊血管醫療設備市場

  • 成年人和老年人
    • 急性病
    • 慢性病
  • 兒童
    • 後天疾病
    • 先天性疾病

第13章 周邊血管醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第14章 周邊血管醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 周邊血管醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 周邊血管醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國周邊血管醫療設備市場

第18章：中國周邊血管醫療設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • ASAHI INTECC CO., LTD
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Kimal PLC
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Penumbra, Inc.
  • Sahajanand Medical Technologies Limited
  • Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • Siemens Healthineers AG
  • Summa Therapeutics, LLC
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market was valued at USD 15.50 billion in 2025 and is projected to grow to USD 16.39 billion in 2026, with a CAGR of 6.26%, reaching USD 23.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.50 billion
Estimated Year [2026] USD 16.39 billion
Forecast Year [2032] USD 23.72 billion
CAGR (%) 6.26%

A focused introduction that frames opportunities and challenges across clinical practice, device innovation, and health systems management

The peripheral vascular devices landscape sits at the intersection of aging demographics, shifting disease burden, and accelerating procedural innovation. Clinicians increasingly rely on a spectrum of devices that span minimally invasive catheter-based therapies to open surgical grafts, and this procedural diversification has elevated the need for integrated clinical pathways that optimize patient outcomes while controlling costs. As a result, hospital systems and ambulatory surgical centers are re-evaluating formularies, device adoption criteria, and inventory strategies to balance efficacy with reproducibility in routine vascular interventions.

Concurrent regulatory evolution is redefining evidence thresholds and post-market surveillance expectations, prompting manufacturers to invest earlier in robust clinical data and to design iterative devices with lifecycle considerations. From a payer perspective, value-based reimbursement constructs and shifting procedure settings are creating new incentives to prioritize devices that demonstrably reduce readmissions, procedural complications, and time to functional recovery. Taken together, these drivers place a premium on cross-disciplinary collaboration among clinical leaders, device developers, and health system purchasers to translate innovation into scalable care delivery improvements.

Looking ahead, companies that harmonize clinical evidence, manufacturing agility, and reimbursement intelligence will capture the strategic advantage required to meet both clinician preferences and institutional procurement standards

A comprehensive view of transformative shifts altering clinical practice, technology adoption, and competitive dynamics across peripheral vascular care

The clinical environment for peripheral vascular devices is undergoing several concurrent shifts that are reshaping adoption patterns and competitive positioning. Minimally invasive techniques continue to expand into patient cohorts previously treated with open surgery, driven by refinements in catheter design, plaque modification technologies, and stent materials. This trend has been enabled by improvements in intraprocedural imaging and navigation, which increase procedural precision and broaden the indications suitable for endovascular approaches. As clinicians and health systems favor less invasive pathways that shorten recovery and reduce hospitalization, manufacturers must emphasize ease-of-use, cross-compatibility, and robust clinical outcomes when designing next-generation solutions.

In parallel, material science advances are prompting renewed attention to long-term biocompatibility and device durability. The shift toward nitinol and cobalt chromium alloys in select classes, along with polymer-based coatings and hybrid materials, reflects a drive to optimize radial strength, deliverability, and endothelialization profiles. Regulatory frameworks and payers are increasingly scrutinizing safety signals and real-world performance, which compels device makers to integrate post-market evidence generation into product strategies. Furthermore, supply chain resilience and localized manufacturing investments are becoming strategic priorities as stakeholders seek to mitigate disruption risks while improving lead times and inventory visibility.

Taken together, these transformative shifts underscore the importance of an evidence-centered commercialization approach that aligns clinical utility with scalable manufacturing and distribution models

An analytical exploration of how the United States tariffs implemented in 2025 are influencing supply chain configurations, sourcing strategies, and commercial operations for device manufacturers

The tariff adjustments introduced in the United States in 2025 have prompted device manufacturers and distributors to reassess global sourcing footprints and contract manufacturing partnerships. While tariffs target specific input categories and finished goods, the broader consequence has been accelerated evaluation of nearshoring opportunities, dual-sourcing provisions, and vertical integration of critical component production. Manufacturers are increasingly modeling total landed costs that account for tariffs, freight volatility, and inventory carrying expenses to inform supplier selection and capital investment decisions. As a result, device developers are prioritizing supplier relationships that offer geographic diversification, quality consistency, and built-in flexibility to scale production in response to demand fluctuations.

Regulatory registration timelines and import compliance considerations are also shaping how firms approach market entry. Companies that rely on multinational supply chains must negotiate additional administrative complexity and potential lead-time extension, particularly for devices with complex multi-component assemblies. Consequently, procurement teams are revisiting contractual terms, adding tariff contingency clauses, and intensifying collaboration with customs and trade compliance experts to preserve margin integrity. For smaller innovators, the tariff environment has increased the comparative attractiveness of licensing agreements or strategic alliances with established manufacturers that already operate compliant, diversified supply chains.

In sum, the 2025 tariff landscape has catalyzed a pragmatic pivot toward resilience and cost transparency, incentivizing investments in supply chain visibility, alternative sourcing, and manufacturing strategies that better absorb trade policy volatility

A detailed synthesis of segmentation insights across product classes, procedural technologies, materials, clinical indications, patient cohorts, and end-user settings to inform targeted commercialization strategies

Product-level heterogeneity defines how clinical and procurement stakeholders evaluate peripheral vascular offerings. The market spans balloon inflation devices, a variety of catheter types, grafts, guidewires, inferior vena cava filters, introducers, plaque modification devices, stents, and vascular closure systems. Within catheters, distinctions among long peripheral intravenous catheters, midline catheters, and short peripheral intravenous catheters influence procedural selection, inventory management, and clinician training priorities. Graft choices reflect material and biological considerations, with biological grafts, expanded polytetrafluoroethylene constructions, and polyester grafts each presenting unique handling characteristics and long-term performance trade-offs. Stent technologies further bifurcate into balloon-expandable and self-expanding designs, which clinicians select based on lesion morphology, vessel sizing, and deliverability requirements.

Technology type segmentation contrasts minimally invasive surgeries with open surgical approaches. Minimally invasive pathways, particularly angioplasty and stenting, prioritize device deliverability, imaging compatibility, and adjunctive tools for plaque modification. Conversely, open surgical interventions such as bypass procedures and endarterectomy necessitate robust graft options, perfusion considerations, and specialized instrumentation. Material differentiation between metal devices and non-metal devices drives choices around radial strength, fatigue resistance, and biocompatibility; metal device subtypes include cobalt chromium, nitinol, and stainless steel, while non-metal alternatives encompass polymers and silicone-based solutions with evolving coating technologies.

Clinical indication and patient-type segmentation also shape commercial priorities. Indications span functional peripheral vascular disease-encompassing chronic venous insufficiency, Raynaud's disease, and varicose veins-and occlusive pathology including atherosclerosis, Buerger's disease, carotid artery disease, deep vein thrombosis, and lymphedema. Patient categories include adult and geriatric cohorts differentiated by acute versus chronic conditions, as well as pediatric populations with acquired or congenital conditions. End-user settings such as ambulatory surgical centers, outpatient clinics, and hospitals each impose different procurement cycles, regulatory oversight, and clinician proficiency expectations. Integrating these segmentation lenses enables companies to align product design, clinical evidence generation, and go-to-market models with the needs of targeted clinical pathways and institutional purchasers

Regional insights that elucidate demand drivers, regulatory environments, infrastructure capacity, and strategic priorities across major global geographies to inform market entry and expansion plans

Regional dynamics materially influence how peripheral vascular devices are adopted, reimbursed, and diffused across care settings. In the Americas, mature healthcare systems, established reimbursement pathways, and high procedure volumes support rapid adoption of novel minimally invasive devices, while divergent payer models and hospital consolidation trends require nuanced contracting approaches. In contrast, Europe, the Middle East and Africa present a mosaic of regulatory heterogeneity and variable infrastructure. European markets often emphasize rigorous clinical evidence and centralized procurement frameworks, whereas Middle Eastern and African markets may prioritize technology that aligns with local clinical expertise and supply chain constraints. These differences necessitate adaptive market access strategies and targeted evidence packages to meet region-specific regulatory and clinical expectations.

The Asia-Pacific region exhibits pronounced heterogeneity in healthcare infrastructure and growth trajectories. Rapid investments in tertiary care centers and increasing procedural capacity in key markets are driving demand for both advanced stent systems and scalable catheter solutions. However, divergent regulatory pathways, local manufacturing incentives, and cost sensitivity require manufacturers to calibrate pricing and localization strategies carefully. Across all regions, health system priorities such as reducing hospital length of stay, improving procedural throughput, and minimizing complication rates serve as universal levers that device developers can address through evidence-based product claims and tailored clinical support programs. Ultimately, a differentiated regional approach that combines rigorous clinical data, regulatory expertise, and operational partnerships will be essential to achieving sustainable adoption across these geographies

Key company insights highlighting competitive positioning, innovation focus areas, partnership dynamics, and strategic imperatives for device manufacturers and service providers

Leading companies in the peripheral vascular device domain are differentiating through a combination of incremental device improvements and platform-level innovations that address procedural efficiency and long-term patient outcomes. Some firms are prioritizing modular systems that enhance cross-compatibility with existing catheter and imaging platforms, whereas others concentrate on material science breakthroughs to optimize deliverability and reduce restenosis. Strategic alliances between device manufacturers and imaging or digital health providers are becoming more common as companies seek to deliver integrated procedural solutions that streamline clinician workflows and support intraoperative decision-making. In addition, partnerships with contract manufacturers and localized production hubs help secure supply chain flexibility and reduce exposure to trade-related disruptions.

Competitive differentiation also hinges on how companies approach clinical evidence and reimbursement support. Firms that invest in pragmatic trial designs, registry partnerships, and health economics dossiers are better positioned to demonstrate value to payers and institutional buyers. For innovators and smaller entrants, licensing agreements, co-development alliances, and targeted collaborations with health systems provide pathways to scale while sharing development risk. Across the competitive landscape, successful players balance near-term commercial execution with longer-term investments in product portfolios that anticipate shifts in clinical practice and regulatory expectations

Actionable recommendations that equip industry leaders to prioritize investments, align clinical evidence strategies, and optimize supply chain resilience for sustained growth

First, prioritize clinical evidence programs that address both short-term procedural outcomes and longer-term patient-centric endpoints. Designing pragmatic studies and registries that integrate seamlessly with routine care pathways will accelerate clinician acceptance and support payer conversations. Second, invest in modularity and interoperability when developing new devices to reduce clinician training friction and increase the likelihood of integration into existing procedural suites. Third, strengthen supply chain visibility and diversify sourcing to minimize exposure to tariff-driven cost fluctuations and logistical bottlenecks. Nearshoring certain components and cultivating redundant supplier relationships can preserve production continuity while optimizing landed costs.

Fourth, tailor market access strategies to regional regulatory and reimbursement nuances, ensuring that localized evidence packages and pricing frameworks reflect clinical priorities and payer thresholds. Fifth, develop clinician-facing value propositions that extend beyond device performance to include training, procedural support, and outcomes-tracking capabilities. Finally, pursue strategic partnerships with imaging and digital health providers to enhance intraoperative decision-making and to generate real-world evidence that supports adoption and reimbursement. By combining evidence-led commercialization with operational resilience and collaborative partnerships, industry leaders can better navigate market complexity and drive sustained clinical and commercial impact

A transparent research methodology explaining the evidence sources, analytic frameworks, and validation steps that underpin the insights and recommendations in the report

The research methodology combines primary interviews with clinical, regulatory, and commercial stakeholders and extensive secondary analysis of peer-reviewed literature, regulatory filings, and publicly available clinical registries. Primary engagements include structured conversations with interventional cardiologists, vascular surgeons, procurement leaders, and senior executives from device firms and contract manufacturers to capture real-world operational constraints and strategic priorities. Secondary research synthesizes device labeling, clinical trial registries, regulatory guidance documents, and published outcomes studies to triangulate performance characteristics and procedural trends.

Analytic frameworks incorporate segmentation analysis across device class, technology type, material composition, clinical indication, patient demographics, and care setting. These frameworks drive cross-sectional comparisons and enable identification of value drivers that influence adoption. Validation steps include cross-referencing primary interview findings with secondary evidence, performing sensitivity checks on thematic conclusions, and conducting peer reviews with clinical experts to ensure the accuracy and relevance of clinical assertions. This rigorous approach ensures that recommendations are grounded in multiple evidence streams and reflect the practical considerations that shape decision-making across clinical and commercial audiences

A concise conclusion that synthesizes implications for stakeholders and frames strategic priorities for the evolving peripheral vascular device ecosystem

The peripheral vascular device environment is characterized by rapid procedural evolution, material innovation, and shifting economic incentives that collectively demand agile, evidence-centered strategies from manufacturers and health systems alike. Clinical pathways are trending toward less invasive approaches in many indications, which places a premium on devices that deliver consistent performance with streamlined procedural workflows. Simultaneously, regulatory and payer expectations are driving deeper commitments to post-market surveillance and outcomes-based evidence, reinforcing the importance of long-term data collection and value demonstration.

To succeed, stakeholders must harmonize device innovation with pragmatic clinical evidence and resilient operational models. This entails investing in interoperable technologies, targeting regionally tailored market access plans, and fortifying supply chains to withstand policy and logistical shocks. Ultimately, companies that can translate clinical differentiation into clear value for clinicians, patients, and payers will be best positioned to capture adoption in a complex and rapidly changing landscape. These strategic priorities should guide near-term tactical decisions and longer-term portfolio investments as the industry moves forward

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Devices Market, by Product

  • 8.1. Balloon Inflation Devices
  • 8.2. Catheters
    • 8.2.1. Long Peripheral Intravenous Catheters
    • 8.2.2. Midline Catheters
    • 8.2.3. Short Peripheral Intravenous Catheter
  • 8.3. Grafts
    • 8.3.1. Biological Grafts
    • 8.3.2. ePTFE Grafts
    • 8.3.3. Polyester Grafts
  • 8.4. Guidewires
  • 8.5. Inferior Vena Cava Filters
  • 8.6. Introducers
  • 8.7. Plaque Modification Devices
  • 8.8. Stents
    • 8.8.1. Balloon-Expandable Stents
    • 8.8.2. Self-Expanding Stents
  • 8.9. Vascular Closure Devices

9. Peripheral Vascular Devices Market, by Technology Type

  • 9.1. Minimally Invasive Surgeries
    • 9.1.1. Angioplasty
    • 9.1.2. Stenting
  • 9.2. Open Surgery
    • 9.2.1. Bypass Surgery
    • 9.2.2. Endarterectomy

10. Peripheral Vascular Devices Market, by Material Type

  • 10.1. Metal Devices
    • 10.1.1. Cobalt Chromium
    • 10.1.2. Nitinol
    • 10.1.3. Stainless Steel
  • 10.2. Non-Metal Devices
    • 10.2.1. Polymer
    • 10.2.2. Silicone

11. Peripheral Vascular Devices Market, by Indication

  • 11.1. Functional Peripheral Vascular Disease
    • 11.1.1. Chronic Venous Insufficiency
    • 11.1.2. Raynaud's Disease
    • 11.1.3. Varicose Veins
  • 11.2. Occlusive Peripheral Vascular Disease
    • 11.2.1. Atherosclerosis
    • 11.2.2. Buerger's Disease
    • 11.2.3. Carotid Artery Disease
    • 11.2.4. Deep Vein Thrombosis
    • 11.2.5. Lymphedema

12. Peripheral Vascular Devices Market, by Patient Types

  • 12.1. Adult & Geriatric
    • 12.1.1. Acute Conditions
    • 12.1.2. Chronic Conditions
  • 12.2. Pediatric
    • 12.2.1. Acquired Conditions
    • 12.2.2. Congenital Conditions

13. Peripheral Vascular Devices Market, by End-User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Peripheral Vascular Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Peripheral Vascular Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Peripheral Vascular Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Peripheral Vascular Devices Market

18. China Peripheral Vascular Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AngioDynamics, Inc.
  • 19.7. Argon Medical Devices, Inc.
  • 19.8. ASAHI INTECC CO., LTD
  • 19.9. B. Braun SE
  • 19.10. Baxter International Inc.
  • 19.11. Becton, Dickinson and Company
  • 19.12. BIOTRONIK SE & Co. KG
  • 19.13. Boston Scientific Corporation
  • 19.14. Cardinal Health, Inc.
  • 19.15. Cook Group Incorporated
  • 19.16. Esaote S.p.A.
  • 19.17. FUJIFILM Holdings Corporation
  • 19.18. GE HealthCare
  • 19.19. Kimal PLC
  • 19.20. Koninklijke Philips N.V.
  • 19.21. Lepu Medical Technology (Beijing) Co., Ltd.
  • 19.22. Medtronic PLC
  • 19.23. Merit Medical Systems, Inc.
  • 19.24. Nipro Corporation
  • 19.25. Penumbra, Inc.
  • 19.26. Sahajanand Medical Technologies Limited
  • 19.27. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • 19.28. Siemens Healthineers AG
  • 19.29. Summa Therapeutics, LLC
  • 19.30. Teleflex Incorporated
  • 19.31. Terumo Corporation
  • 19.32. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON INFLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MIDLINE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY EPTFE GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYESTER GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INFERIOR VENA CAVA FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INTRODUCERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BYPASS SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ENDARTERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY RAYNAUD'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY BUERGER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CAROTID ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY LYMPHEDEMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACUTE CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CHRONIC CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ACQUIRED CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CONGENITAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)